A reversible mono-amine oxidase inhibitor (MAOI) used to manage depression and performance anxiety. It is not approved for use in the USA.
Adverse effects
Insomnia, headache, dizziness.


Moclobemide, see there.
References in periodicals archive ?
The product rights to Flupirtine, Onsolis and Sublinox are returned to Meda, and Valeant will continue to run the business in Canada, including the products Palafer, Contac, and Manerix.